Karin Bartel

932 total citations
28 papers, 695 citations indexed

About

Karin Bartel is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Karin Bartel has authored 28 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Physiology and 7 papers in Pharmacology. Recurrent topics in Karin Bartel's work include Calcium signaling and nucleotide metabolism (12 papers), Ion Channels and Receptors (6 papers) and Berberine and alkaloids research (4 papers). Karin Bartel is often cited by papers focused on Calcium signaling and nucleotide metabolism (12 papers), Ion Channels and Receptors (6 papers) and Berberine and alkaloids research (4 papers). Karin Bartel collaborates with scholars based in Germany, United States and Japan. Karin Bartel's co-authors include Angelika M. Vollmar, Christian Grimm, Martin Biel, Martin Müller, Yu‐Kai Chao, Franz Bracher, Christian Wahl‐Schott, Melanie Ulrich, Ong Nam Phuong Nguyen and Rolf Müller and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Karin Bartel

26 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Bartel Germany 14 300 290 162 104 101 28 695
Kateryna Kondratska France 11 59 0.2× 333 1.1× 184 1.1× 80 0.8× 47 0.5× 12 622
Antonella Managò Italy 12 63 0.2× 449 1.5× 41 0.3× 101 1.0× 21 0.2× 13 697
Marscha Hirschi United States 8 61 0.2× 354 1.2× 119 0.7× 12 0.1× 27 0.3× 10 547
James I. Fells United States 18 62 0.2× 717 2.5× 20 0.1× 29 0.3× 201 2.0× 27 848
Antonella D’Amore Italy 9 58 0.2× 121 0.4× 33 0.2× 17 0.2× 30 0.3× 19 314
Rajesh Bhardwaj Switzerland 15 24 0.1× 231 0.8× 286 1.8× 20 0.2× 35 0.3× 26 583
Antonio Caldarelli Italy 13 25 0.1× 221 0.8× 21 0.1× 49 0.5× 16 0.2× 21 590
L. Nedyalkova Canada 9 75 0.3× 301 1.0× 5 0.0× 39 0.4× 42 0.4× 9 528
Benjamin Fränzel Germany 14 37 0.1× 464 1.6× 6 0.0× 96 0.9× 122 1.2× 18 721
Peiliang Shen China 13 11 0.0× 228 0.8× 44 0.3× 36 0.3× 20 0.2× 23 485

Countries citing papers authored by Karin Bartel

Since Specialization
Citations

This map shows the geographic impact of Karin Bartel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Bartel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Bartel more than expected).

Fields of papers citing papers by Karin Bartel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Bartel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Bartel. The network helps show where Karin Bartel may publish in the future.

Co-authorship network of co-authors of Karin Bartel

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Bartel. A scholar is included among the top collaborators of Karin Bartel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Bartel. Karin Bartel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kany, Andreas M., Karin Bartel, Norbert Reiling, et al.. (2025). Design, Synthesis, and Biological Evaluation of Mono- and Diamino-Substituted Squaramide Derivatives as Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthase. Journal of Medicinal Chemistry. 68(23). 25274–25289.
2.
Bartel, Karin, et al.. (2025). Zephycandidine A and Synthetic Analogues—Synthesis and Evaluation of Biological Activity. Molecules. 30(3). 752–752. 1 indexed citations
3.
Tang, Rachel, et al.. (2024). TPC2: From Blond Hair to Melanoma?. Cancers. 16(23). 4065–4065.
4.
Thorn‐Seshold, Julia, et al.. (2023). Endolysosomal TRPML1 channel regulates cancer cell migration by altering intracellular trafficking of E-cadherin and β1-integrin. Journal of Biological Chemistry. 300(1). 105581–105581. 5 indexed citations
5.
Kabiri, Yaschar, Rachel Tang, Yu‐Kai Chao, et al.. (2022). Lysosomal TRPML1 regulates mitochondrial function in hepatocellular carcinoma cells. Journal of Cell Science. 135(6). 22 indexed citations
6.
Müller, Martin, et al.. (2022). Targeting TPC2 sensitizes acute lymphoblastic leukemia cells to chemotherapeutics by impairing lysosomal function. Cell Death and Disease. 13(8). 668–668. 15 indexed citations
7.
Müller, Martin, Yu‐Kai Chao, Ong Nam Phuong Nguyen, et al.. (2021). Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growth. Cell chemical biology. 28(8). 1119–1131.e27. 44 indexed citations
8.
Krauß, Jürgen, Christoph Müller, Martin Müller, et al.. (2021). Synthesis, Biological Evaluation, and Structure–Activity Relationships of 4-Aminopiperidines as Novel Antifungal Agents Targeting Ergosterol Biosynthesis. Molecules. 26(23). 7208–7208. 9 indexed citations
10.
Tang, Rachel, Cheng‐Chang Chen, Anna Scotto Rosato, et al.. (2021). Flavonoids increase melanin production and reduce proliferation, migration and invasion of melanoma cells by blocking endolysosomal/melanosomal TPC2. Scientific Reports. 11(1). 8515–8515. 44 indexed citations
11.
Giopanou, Ioanna, Adam Hermawan, Stefan Datz, et al.. (2020). Synergistic Combination of Calcium and Citrate in Mesoporous Nanoparticles Targets Pleural Tumors. Chem. 7(2). 480–494. 13 indexed citations
12.
Müller, Martin, et al.. (2020). Synthesis, biological evaluation and toxicity of novel tetrandrine analogues. European Journal of Medicinal Chemistry. 207. 112810–112810. 11 indexed citations
13.
Dahlem, Charlotte, William Ka Fai Tse, Sonja M. Kessler, et al.. (2020). Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism. Cancers. 12(5). 1288–1288. 27 indexed citations
14.
Vollmar, Angelika M., et al.. (2020). Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa?. Pharmaceuticals. 13(7). 143–143. 13 indexed citations
15.
Müller, Martin, et al.. (2020). Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review. Frontiers in Oncology. 10. 1156–1156. 68 indexed citations
16.
Bartel, Karin, Helmut Pein, Bastian Popper, et al.. (2019). Connecting lysosomes and mitochondria – a novel role for lipid metabolism in cancer cell death. Cell Communication and Signaling. 17(1). 87–87. 34 indexed citations
17.
Senger, Johanna, Daniel Herp, Martin Marek, et al.. (2019). Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors. Journal of Medicinal Chemistry. 62(3). 1138–1166. 77 indexed citations
18.
Chen, Cheng‐Chang, Elisabeth Butz, Anna Scotto Rosato, et al.. (2018). Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells. eLife. 7. 77 indexed citations
19.
Chao, Yu‐Kai, Martin Biel, Franz Bracher, et al.. (2018). Reversal of Chemoresistance in Leukemia Cells Using Synthetic Bisbenzylisoquinoline Derivatives. Blood. 132(Supplement 1). 3504–3504. 1 indexed citations
20.
Bartel, Karin, et al.. (1999). Optimal Tobramycin Dosage in Patients with Cystic Fibrosis - Evidence for Predictability Based on Previous Drug Monitoring. Infection. 27(4-5). 268–271. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026